Lower hemisternotomy: infrequently used but versatile.


Journal

The Journal of cardiovascular surgery
ISSN: 1827-191X
Titre abrégé: J Cardiovasc Surg (Torino)
Pays: Italy
ID NLM: 0066127

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 23 2 2021
medline: 21 10 2021
entrez: 22 2 2021
Statut: ppublish

Résumé

A lower hemisternotomy is an infrequently used approach in cardiac surgery. This single center report evaluates applicability and clinical outcomes of procedures performed through a lower hemisternotomy. The institutional database was reviewed. From 2014 to 2019, 55 consecutive patients had undergone minimally invasive procedures through a lower hemisternotomy (median follow-up 34 months). Demographic as well as outcome data were retrieved from our prospectively maintained institutional database. Performed procedures included mitral and tricuspid repairs, aortic valve replacement as well as coronary artery bypass grafting. The median patient age was 72 years. Out of the 55 patients, 55% were male. Predominantly mitral valve procedures (11 isolated, 30 combined) had been performed. Mitral valve procedures (N.=41) consisted of 36 repairs and 5 replacements. Repair rate for degenerative mitral insufficiency was 97.6%. Median EuroScore II was 3.4% (2.1-6.0). Median cross-clamp time was 67 (44-99) min. Median procedural length was 169 (138-201) min. Reoperation rate for bleeding was 1.8%. Major vascular complications occurred in two patients. Freedom from valve related reoperation was 96.1% during follow-up. Thirty-day mortality and overall mortality during follow-up was 3.6% and 10.9%. In properly selected cases the lower hemisternotomy allows for a variety of cardiac procedures. It permits central aortic cannulation and a direct vision of intracardiac structures and therefore should be kept in mind as an alternative minimally invasive approach.

Sections du résumé

BACKGROUND BACKGROUND
A lower hemisternotomy is an infrequently used approach in cardiac surgery. This single center report evaluates applicability and clinical outcomes of procedures performed through a lower hemisternotomy.
METHODS METHODS
The institutional database was reviewed. From 2014 to 2019, 55 consecutive patients had undergone minimally invasive procedures through a lower hemisternotomy (median follow-up 34 months). Demographic as well as outcome data were retrieved from our prospectively maintained institutional database.
RESULTS RESULTS
Performed procedures included mitral and tricuspid repairs, aortic valve replacement as well as coronary artery bypass grafting. The median patient age was 72 years. Out of the 55 patients, 55% were male. Predominantly mitral valve procedures (11 isolated, 30 combined) had been performed. Mitral valve procedures (N.=41) consisted of 36 repairs and 5 replacements. Repair rate for degenerative mitral insufficiency was 97.6%. Median EuroScore II was 3.4% (2.1-6.0). Median cross-clamp time was 67 (44-99) min. Median procedural length was 169 (138-201) min. Reoperation rate for bleeding was 1.8%. Major vascular complications occurred in two patients. Freedom from valve related reoperation was 96.1% during follow-up. Thirty-day mortality and overall mortality during follow-up was 3.6% and 10.9%.
CONCLUSIONS CONCLUSIONS
In properly selected cases the lower hemisternotomy allows for a variety of cardiac procedures. It permits central aortic cannulation and a direct vision of intracardiac structures and therefore should be kept in mind as an alternative minimally invasive approach.

Identifiants

pubmed: 33616351
pii: S0021-9509.21.11670-2
doi: 10.23736/S0021-9509.21.11670-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

496-501

Auteurs

Andreas Voetsch (A)

Department of Cardiovascular and Endovascular Surgery, Paracelsus Medical University, Salzburg, Austria.

Andreas Winkler (A)

Department of Cardiovascular and Endovascular Surgery, Paracelsus Medical University, Salzburg, Austria.

Philipp Krombholz-Reindl (P)

Department of Cardiovascular and Endovascular Surgery, Paracelsus Medical University, Salzburg, Austria.

Matthias Neuner (M)

Department of Anesthesia and Intensive Care, Paracelsus Medical University, Salzburg, Austria.

Michael Kirnbauer (M)

Department of Anesthesia and Intensive Care, Paracelsus Medical University, Salzburg, Austria.

Rainald Seitelberger (R)

Department of Cardiovascular and Endovascular Surgery, Paracelsus Medical University, Salzburg, Austria.

Roman Gottardi (R)

Department of Cardiovascular and Endovascular Surgery, Paracelsus Medical University, Salzburg, Austria - roman.gottardi@gmail.com.
Department of Cardiac, Thoracic and Vascular Surgery, Mediclin Heart Institute Lahr/Baden, Lahr, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH